Home Clinical Trials at Duke Clinical Trials Directory

Adaptive PET II for Reproductive and Digestive Cancer - Clinical Trial

Call to Participate

What is the Purpose of this Study?

We are doing this study to understand the benefit of using PET scan in addition to the standard of care CT scan to plan for radiation therapy. The PET-CT scan may allow your radiation doctor to fine tune the radiation plan or the delivery of radiation to your cancer.

What is the Condition Being Studied?

Reproductive and Digestive Cancer

Who Can Participate in the Study?

Adults who:

  • Are diagnosed with cervical or vulvar (female reproductive tract), esophageal or anal canal (digestive tract) cancer
  • Have a negative pregnancy test
Age Group
Adults

What is Involved?

If you choose to join this study, you will:

  • Have 2 PET scans in addition to computed tomography (CT) scans
  • Have the first PET-CT scan before the start of radiation therapy
  • Have the second PET-CT scan during radiation therapy
  • Be involved in the study for about 6-8 weeks

    • Study Details

    Full Title
    Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers (Adaptive PET II)
    Principal Investigator
    Junzo P. Chino, MD
    Radiation Oncologist
    Protocol Number
    IRB: PRO00089619
    NCT: NCT03403465
    Phase
    Phase N/A
    ClinicalTrials.gov
    Enrollment Status
    Open for Enrollment
    Participate
    Contact the Duke Recruitment Innovation Center
    MyResearchPartners@duke.edu
    or
    919-681-5698

    Follow us on Facebook and Instagram.